2. Search Result
Search Result
Results for "

JNJ-75276617

" in MedChemExpress (MCE) Product Catalog:
製品番号 製品名 Target 研究分野 構造式
  • HY-148669
    Bleximenib
    1 Publications Verification

    JNJ-75276617; Menin-MLL inhibitor 24

    		 Apoptosis Histone Methyltransferase FLT3 Cancer
    Bleximenib (JNJ-75276617) is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib can be used in the research of tumors such as leukemia .
    Bleximenib
  • HY-148669A
    Bleximenib oxalate
    1 Publications Verification

    JNJ-75276617 oxalate; Menin-MLL inhibitor 24 oxalate

    		 Apoptosis Histone Methyltransferase FLT3 Cancer
    Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia .
    Bleximenib oxalate
  • HY-148669B
    (S)-Bleximenib oxalate

    (S)-JNJ-75276617 oxalate; (S)-Menin-MLL inhibitor 24 oxalate

    		 Apoptosis Histone Methyltransferase FLT3 Cancer
    (S)-Bleximenib (oxalate) is a S-Enantiomer of Bleximenib oxalate (HY-148669A). Bleximenib (JNJ-75276617) oxalate is an orally active and selective menin-KMT2A inhibitor, with IC50 values of 0.1 nM, 0.045 nM, and ≤0.066 nM for humans, mice, and dogs, respectively. Bleximenib oxalate can inhibit the proliferation and induce apoptosis and differentiation of tumor cells. Bleximenib oxalate can be used in the research of tumors such as leukemia .
    (S)-Bleximenib oxalate
  • HY-155797
    (S)-Bleximenib

    (S)-JNJ-75276617; (S)-Menin-MLL inhibitor 24

    		 Drug Isomer HOXA Cancer
    (S)-Bleximenib (Compound 28) ((S)-JNJ-75276617) is an isoform of Bleximenib (HY-148669). (S)-Bleximenib shows an IC50 greater than 1 μM in the MEIS1 mRNA expression assay. (S)-Bleximenib can be used in the research of acute myeloid leukemia .
    (S)-Bleximenib

オンラインお問い合わせ

入力情報は安全に管理されます. ※ 必須入力項目.

タイトル

  

国或いは地域 *

お名前 *

 

組纖名 *

デパートメント *

     

メールアドレス *

 

製品名 *

製品番号

  

カスタマ需要量 *

電話番号 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
製品番号:
数量:
MCE 日本正規代理店: